title: Etomidate in the emergency management of hypercortisolemia.
abstract: We describe a protocol for etomidate infusion for the emergency management of hypercortisolemia. Etomidate is commenced at 2.5 mg/h and titrated subsequently according to cortisol levels. It is well tolerated without any sedative effects and can be administered safely via peripheral access for use in the general ward setting.
authors.forename: Lip Min
authors.initials: LM
authors.lastname: Soh
authors.forename: Kirun
authors.initials: K
authors.lastname: Gunganah
authors.forename: Scott A
authors.initials: SA
authors.lastname: Akker
authors.forename: Philip
authors.initials: P
authors.lastname: Jones
authors.forename: Hasanin
authors.initials: H
authors.lastname: Khachi
authors.forename: Kumbirai
authors.initials: K
authors.lastname: Dodzo
authors.forename: William M
authors.initials: WM
authors.lastname: Drake
mesh_terms: D003480:Cushing Syndrome / Q000188:drug therapy*; D005045:Etomidate / Q000627:therapeutic use*; D006801:Humans
chemical_list: D005045:Etomidate